Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ZTI BIOSCIENCES logo — Radiopharmaceutical Platform: Fully-integrative Nano-Carrier...

ZTI BIOSCIENCES

Radiopharmaceutical Platform: Fully-integrative Nano-Carrier Platform, compatible with any Ligands or radio Isotopes.

Founded 2020 Korea South Korea South 20 employees Series A Total: $1.95B Biotechnology, Pharmaceutical

General Information

Company Name ZTI BIOSCIENCES
Founded Year 2020
Location Korea South Korea South +3
Employees 20
Industries Biotechnology, Pharmaceutical
Funding Stage Series A
Social

Get notified when ZTI BIOSCIENCES moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ZTI BIOSCIENCES

ZTI BIOSCIENCES is a South Korea-based biotechnology startup, established in 2020, focusing on the development of radiopharmaceuticals for cancer therapy. The company's core technology revolves around a Fully-integrative Nano-Carrier Platform, designed to address the limitations of traditional radiopharmaceuticals. ZTI's proprietary TERACARRIER prevents the detachment of radioactive payloads upon injection into the body, offering a solution to the fundamental weakness of existing radiopharmaceuticals. The company's TERACARRIER platform is touted to be compatible with any Ligands or Radio Isotopes, significantly enhancing the efficacy of targeting ligands while reducing the side effects associated with free radioisotopes. ZTI's nanotech materials promise to unlock the full potential of radioisotopes, with a focus on standardizing the advancement of radiopharmaceuticals, notably starting with Iodine-131, a radioisotope with vast untapped potential. In September 2021, ZTI BIOSCIENCES secured a significant KRW1.50B Series A investment, with participation from notable investors including STIC, Kiwoom Investment, TIGRIS Investment, Stick Ventures, and the Korea Credit Guarantee Fund. This funding is expected to fuel the company's efforts in revolutionizing cancer therapy through innovative radiopharmaceutical solutions.

Taxonomy: Radiopharmaceuticals, Nano-material technology, Biotech, Nuclear medicine, TERACARRIER, Ligands, Radioisotopes, Cancer therapy, Nanotech materials, Radioisotope therapy, Biomedical technology, Iodine-131, Lutetium-177, Actinium-225, Radioligand therapy

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 5
Investor Investor Investor
•••• •••• 		30 Sep 2021
Seed Round •••••• 2
Investor
•••• •••• 		30 Sep 2020

ZTI BIOSCIENCES Alternatives & Competitors

ZTI BIOSCIENCES vs
3D Glass Solutions, Inc.
3D Glass Solutions, Inc. United States

A New Dimension for Electronics

Series C
47 employees
ZTI BIOSCIENCES vs
Raccoon.Recovery
Raccoon.Recovery Germany

Raccoon.Recovery is a rehabilitation tool with machine learning and gaming for treating patients and...

11-50 employees
Information Technology
ZTI BIOSCIENCES vs
Jam.gg
Jam.gg United States

From retro gaming platform to democratizing cloud gaming, we empower devs to put games on their clou...

Series A
16 employees
Cloud Infrastructure, Gaming

FAQ About ZTI BIOSCIENCES

Radiopharmaceutical Platform: Fully-integrative Nano-Carrier Platform, compatible with any Ligands or radio Isotopes.
ZTI BIOSCIENCES was founded in 2020.
ZTI BIOSCIENCES is headquartered in Korea South.
ZTI BIOSCIENCES operates in the following industries: Biotechnology, Pharmaceutical.
ZTI BIOSCIENCES has approximately 20 employees.
ZTI BIOSCIENCES has completed 2 funding rounds, raising a total of $1.95B. The latest funding stage is Series A.
Top alternatives and competitors to ZTI BIOSCIENCES include 3D Glass Solutions, Inc., Raccoon.Recovery, Jam.gg, Corteza Project, DeskNet Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ZTI BIOSCIENCES and 3D Glass Solutions, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ZTI BIOSCIENCES and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy